RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2000; 84(05): 920-921
DOI: 10.1055/s-0037-4140
DOI: 10.1055/s-0037-4140
Letters to the Editor
Improving Methods to Assess Therapeutic Quality Control of Treatment with Oral Anticoagulants
Autoren
Weitere Informationen
Publikationsverlauf
Received
15. März 2000
Accpeted after revision
30. Mai 2000
Publikationsdatum:
13. Dezember 2017 (online)
-
References
- 1 Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D, Brandt JT. Oral anticoagulants. Mechanisms of action, clinical effectiveness and optimal therapeutic range. Chest 1998; 114: 445S-69S.
- 2 Duxbury BmcD. Therapeutic control of anticoagulant treatment. Br Med J 1982; 284: 702-4.
- 3 Rosendaal FR, Cannegieter SC, Van der Meer FJM, Vandenbroucke JP, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
- 4 Hutten BA, Prins MH, Redekop WK, Tijssen JGP, Heisterkamp SH, Büller HR. Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists. Thromb Haemost 1999; 82: 1260-3.
- 5 Marco F, Lopez MDuarte, Sedano C, Bermudez A, Perez RMontes, Carreter E, Fernández EFontecha, Ontañon A, Conde E, Zubizarreta A. Computerised oral anticoagulant dosage: a prospective randomized study of 5568 tests. Blood 1999; 94 (suppl 1, part 2): 109b.